DeepMed Research

ICAHN School of Medicine At Mount Sinai

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1963-01-01

Employees: 5K

Market Cap: -

Website: http://www.mssm.edu

Clinical Trials

NYCKidSeq: Incorporating Genomics Into Clinical Care of Diverse NYC Children

Not Applicable

Completed

Conditions: Genetic Diseases, Inborn
Genetic Predisposition to Disease

Interventions: Behavioral: Standard of Care
Behavioral: GUÍA

First Posted Date: 2018-11-13

Last Posted Date: 2023-12-13

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 650

Registration Number: NCT03738098

Locations: 🇺🇸
Albert Einstein College of Medicine/Montefiore, Bronx, New York, United States
🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States

DDX3X Syndrome -The Seaver Autism Center for Research and Treatment is Characterizing DDX3X-related Neurodevelopmental Disorders Using Genetic, Medical, and Neuropsychological Measures.

Recruiting

Conditions: DDX3X
Autism Spectrum Disorder
Mental Retardation, X-linked 102

First Posted Date: 2018-10-25

Last Posted Date: 2024-05-10

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 10

Registration Number: NCT03718910

Locations: 🇺🇸
The Seaver Autism Center for Research and Treatment, New York, New York, United States

FOXP1 Syndrome: The Seaver Autism Center for Research and Treatment is Characterizing FOXP1-related Neurodevelopmental Disorders Using Genetic, Medical, and Neuropsychological Measures.

Recruiting

Conditions: FOXP1
Mental Retardation With Language Impairment and With or Without Autistic Features
Autism Spectrum Disorder

First Posted Date: 2018-10-25

Last Posted Date: 2025-04-09

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 50

Registration Number: NCT03718923

Locations: 🇺🇸
The Seaver Autism Center for Research and Treatment, New York, New York, United States

ADNP Syndrome: The Seaver Autism Center for Research and Treatment is Characterizing ADNP-related Neurodevelopmental Disorders Using Genetic, Medical, and Neuropsychological Measures.

Recruiting

Conditions: ADNP
Autism Spectrum Disorder
Helsmoortel-Van Der Aa Syndrome

First Posted Date: 2018-10-25

Last Posted Date: 2025-05-09

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 30

Registration Number: NCT03718936

Locations: 🇺🇸
The Seaver Autism Center for Research and Treatment, New York, New York, United States

Evaluation of an EEG Based Concussion System

Recruiting

Conditions: Concussion

Interventions: Other: EEG

First Posted Date: 2018-10-17

Last Posted Date: 2025-05-14

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 150

Registration Number: NCT03710109

Locations: 🇺🇸
Mount Sinai Beth Israel Hospital, New York, New York, United States
🇺🇸
Abilities Research Center, New York, New York, United States

Improving Medication Adherence in Adolescents Who Had a Liver Transplant

Not Applicable

Completed

Conditions: Transplant

Interventions: Behavioral: Telemetric Intervention

First Posted Date: 2018-10-01

Last Posted Date: 2025-03-04

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 148

Registration Number: NCT03691220

Locations: 🇺🇸
Children's Hospital Los Angeles, Los Angeles, California, United States
🇺🇸
Mattel Children's Hospital UCLA, Los Angeles, California, United States
🇺🇸
Miami Transplant Institute, Miami, Florida, United States

and more 10 locations

The Effect of Platelet Rich Plasma on Non-scarring Alopecia

Not Applicable

Completed

Conditions: Androgenetic Alopecia
Alopecia

Interventions: Drug: Normal saline
Device: Platelet Rich Plasma

First Posted Date: 2018-09-28

Last Posted Date: 2020-10-30

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 30

Registration Number: NCT03689452

Locations: 🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States

Aczone Gel 7.5% in the Treatment of Acne Vulgaris in Patients With Skin of Color

Phase 4

Completed

Conditions: Acne Vulgaris

Interventions: Drug: Aczone Gel

First Posted Date: 2018-09-24

Last Posted Date: 2022-07-27

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 20

Registration Number: NCT03681470

Locations: 🇺🇸
Mount Sinai West, New York, New York, United States

Toward Safer Opioid Prescribing for Chronic Pain in High Risk Populations

Completed

Conditions: HIV Disease
Chronic Pain

Interventions: Other: Communication Strategy
Other: Standard of Care

First Posted Date: 2018-09-13

Last Posted Date: 2020-10-09

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 42

Registration Number: NCT03669939

Locations: 🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States

Prophylactic NPWT to Reduce SSI in Colorectal Surgery

Not Applicable

Terminated

Conditions: Surgical Wound Infection

Interventions: Device: Prevena

First Posted Date: 2018-09-07

Last Posted Date: 2020-12-17

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 7

Registration Number: NCT03661814

Locations: 🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy